{"id":150789,"date":"2026-11-12T19:12:32","date_gmt":"2026-11-12T10:12:32","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/4526-20261112-02_wp_business_update\/"},"modified":"2026-11-12T19:12:32","modified_gmt":"2026-11-12T10:12:32","slug":"4526-20261112-02_wp_business_update","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/","title":{"rendered":"Notice Regarding Revision of the Medium-Term Management Plan 2027"},"content":{"rendered":"<p>Resolution to revise the Medium-Term Management Plan 2027. Reduce the proportion of low-margin commodity products in overseas operations and shift to specialty products; review the production system at Rikevita Malaysia. Numerical targets for the fiscal year ending March 2028 have been revised and the dividend policy will also be reviewed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4526","jir_company_name":"Riken Vitamin Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4526-20261112-02.pdf","jir_short_summary":"Resolution to revise the Medium-Term Management Plan 2027. Reduce the proportion of low-margin commodity products in overseas operations and shift to specialty products; review the production system at Rikevita Malaysia. Numerical targets for the fiscal year ending March 2028 have been revised and the dividend policy will also be reviewed.","jir_summary":"### Background and Policy for Revising the Medium-Term Plan\nThe Company resolved to revise the Medium-Term Management Plan 2027. To respond to structural changes in overseas markets, the Group will reduce the proportion of low-margin commodity products and accelerate the shift to specialty products. The Company will review the production system at its largest overseas manufacturing site, Rikevita Malaysia. Accordingly, management targets and measures under the plan will be reassessed, and the dividend policy will also be reviewed.\n\n### Numerical Targets and Dividend Policy for the Fiscal Year Ending March 2028\nRevised numerical targets are net sales of 1,050 hundred million yen, operating income of 80 hundred million yen, EBITDA of 122 hundred million yen, ROE of 10%, and an increase in the shareholders' equity ratio to approximately 70%. The dividend policy has been revised. For details of the revised dividend policy and adjustments to dividend forecasts (increase), refer to the separate notice titled \"Notice Regarding Change in Dividend Policy and Revision of Dividend Forecast (Dividend Increase)\".","jir_financial_highlights":"Net Sales: Before: 1,100 hundred million yen \u2192 After: 1,050 hundred million yen (Revised)\nOperating Income: Before: 100 hundred million yen \u2192 After: 80 hundred million yen (Revised)\nEBITDA: Before: 142 hundred million yen \u2192 After: 122 hundred million yen (Revised)\nROE: Before: Over 10% \u2192 10% (Revised)\nDividend Policy: Before: Payout ratio of 40% or more and progressive dividends with DOE floor of 4% \u2192 After: Unknown (Revised)\nShareholders' Equity Ratio: Before: 60\u201365% \u2192 Approx. 70% (Revised)","jir_category":"","jir_hashtags":"#RikenVitamin, #MediumTermPlanRevision","jir_key_figures":"Net Sales: 1,050 hundred million yen (revised)\nOperating Income: 80 hundred million yen (revised)\nEBITDA: 122 hundred million yen (revised)","jir_meta_title":"Riken Vitamin Co., Ltd. \u2014 Revision of Medium-Term Management Plan 2027 | Net Sales Revised to 1,050 hundred million yen & Dividend Policy Review","jir_meta_description":"Riken Vitamin Co., Ltd. announced a revision of its Medium-Term Management Plan 2027. Measures include reducing low-margin commodity products in overseas operations, expanding specialty products, and reviewing the production system at Rikevita Malaysia. This article outlines the revised targets and changes to the dividend policy for fiscal 2028.","jir_og_title":"Riken Vitamin Co., Ltd. Announces Revision of Medium-Term Plan 2027","jir_og_description":"Riken Vitamin Co., Ltd. has announced a revision to its Medium-Term Management Plan 2027, including a strategic review of overseas operations and changes to the dividend policy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16690,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-150789","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Revision of the Medium-Term Management Plan 2027 - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/\",\"name\":\"Notice Regarding Revision of the Medium-Term Management Plan 2027 - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-11-12T10:12:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Revision of the Medium-Term Management Plan 2027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Revision of the Medium-Term Management Plan 2027 - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/","url":"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/","name":"Notice Regarding Revision of the Medium-Term Management Plan 2027 - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-11-12T10:12:32+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4526\/ir\/4526-20261112-02_wp_business_update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Revision of the Medium-Term Management Plan 2027"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"16690","title":"RIKEN VITAMIN CO","ticker":"4526"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/150789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=150789"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/150789\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=150789"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=150789"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=150789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}